The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients
The binding of drugs to plasma protein is frequently altered in certain types of renal diseases. We recently reported on the effects of oxidation and uremic toxins on the binding of aripiprazole (ARP) to human serum albumin. In our continuing investigations, we examined the binding of ARP to plasma...
Guardado en:
Autores principales: | Kenshiro Hirata, Tokunori Ikeda, Hiroshi Watanabe, Toru Maruyama, Motoko Tanaka, Victor Tuan Giam Chuang, Yuji Uchida, Keiki Sakurama, Koji Nishi, Keishi Yamasaki, Masaki Otagiri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5521bd7ff6104aa1a466933dd37f6b68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Omega-3 Polyunsaturated Fatty Acid Attenuates Uremia-Induced Brain Damage in Mice
por: Eun-Ji Kim, et al.
Publicado: (2021) -
Perfil de susceptibilidad a los antimicrobianos en cepas de E coli productoras de Shiga toxina (STEC) aisladas de infecciones humanas y de alimentos
por: Reyes S,Marcelo, et al.
Publicado: (2004) -
Aripiprazole for late-life schizophrenia
por: Jeffrey Rado, et al.
Publicado: (2010) -
Aripiprazole en el tratamiento sintomático del síndrome de Gilíes de la Tourette (enfermedad de los tics)
por: Miranda C,Marcelo, et al.
Publicado: (2007) -
Healthy and Chronic Kidney Disease (CKD) Dogs Have Differences in Serum Metabolomics and Renal Diet May Have Slowed Disease Progression
por: Marcio Antonio Brunetto, et al.
Publicado: (2021)